Rapid medical diagnosis of influenza might help reduce length of hospital stays, secondary complications and the cost of hospital care, and allow effective implementation of an infection control procedures. Alere i Influenza A & B is currently under regulatory review in the United States by the united states Food and Drug Administration and isn’t available in the united states pending completion of such review.. Alere i Influenza A & B test available in Europe now Alere Inc. The test is currently commercially available in Austria, France, Spain, Switzerland, Germany, Italy and the UK. ‘Alere i also significantly expands screening opportunities by making innovative, quick molecular testing technology available at the true point of care and also in laboratory settings. Alere i Influenza A & B is the initial molecular diagnostic test that delivers actionable, lab-accurate results in under 15 minutes on a user-friendly platform.As happen to be the mountains for professional and recreational activities is increasingly popular, involving millions of persons worldwide, the estimated amount of patients with obstructive sleep apnea among mountain visitors can be high, and may involve several hundred thousand persons every year, which might expose them to hypoxemia and exacerbation of sleep apnea. ‘The treatment in this setting isn’t established,’ according to background information in this article. Tsogyal D. Latshang, M.D., of the University of Zurich, Switzerland, and colleagues conducted a report to evaluate whether acquiring of the medication acetazolamide coupled with auto-adjusted constant positive airway pressure would offer better oxygenation and control of sleep-related breathing disturbances than autoCPAP alone in patients with OSA spending a few days at moderate altitude.